81 related articles for article (PubMed ID: 3551995)
1. [A double-blind clinical trial of a topical preparation with a base of biochemical precursors of glucosaminoglycan (GAG) in patients suffering from Raynaud's disease].
Signorini GP
Boll Chim Farm; 1986 Oct; 125(10):103S-110S. PubMed ID: 3551995
[No Abstract] [Full Text] [Related]
2. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
Rhedda A; McCans J; Willan AR; Ford PM
J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
[TBL] [Abstract][Full Text] [Related]
3. Double-blind randomized trial of nitroderm TTS in the treatment of Raynaud's phenomenon.
Nahir AM; Schapira D; Scharf Y
Isr J Med Sci; 1986 Feb; 22(2):139-42. PubMed ID: 3081460
[No Abstract] [Full Text] [Related]
4. [Nicardipine in the treatment of Raynaud's phenomenon].
Kahan A; Amor B; Menkès CJ
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
[TBL] [Abstract][Full Text] [Related]
5. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
Sauza J; Kraus A; González-Amaro R; Alarcón-Segovia D
J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
[TBL] [Abstract][Full Text] [Related]
6. A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
van der Meer J; Wouda AA; Kallenberg CG; Wesseling H
Vasa Suppl; 1987; 18():71-5. PubMed ID: 3299819
[No Abstract] [Full Text] [Related]
7. Thymoxamine for Raynaud's disease and chilblains.
Jaffe GV; Grimshaw JJ
Br J Clin Pract; 1980; 34(11-12):343-6. PubMed ID: 6450602
[No Abstract] [Full Text] [Related]
8. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
Baadsgaard O; Schmidt JF; Ironmann L
Ugeskr Laeger; 1983 Dec; 145(49):3814-6. PubMed ID: 6364517
[No Abstract] [Full Text] [Related]
9. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
Rodeheffer RJ; Rommer JA; Wigley F; Smith CR
N Engl J Med; 1983 Apr; 308(15):880-3. PubMed ID: 6339921
[No Abstract] [Full Text] [Related]
10. [Local treatment with isosorbide dinitrate ointment in Raynaud's phenomenon].
Diehm C; Müller-Bühl U; Mechterscheimer U; Mörl H
Vasa; 1984; 13(1):72-4. PubMed ID: 6367258
[No Abstract] [Full Text] [Related]
11. Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.
Allegra C; Tonelli V; Bonifacio M; Mari A; Assogna G
Boll Chim Farm; 1985 Oct; 124(10):121S-124S. PubMed ID: 2935173
[No Abstract] [Full Text] [Related]
12. [Raynaud's disease treated with captopril (Capoten). A randomized double-blind cross-over study].
Madsen JL; Hvidt S
Ugeskr Laeger; 1984 Sep; 146(36):2695-7. PubMed ID: 6393495
[No Abstract] [Full Text] [Related]
13. [Use of nifedipine in patients with Raynaud's phenomenon].
Rozwodowska M; Polaszewska-Muszyńska M; Ukleja-Adamowicz M; Rewakowicz M; Guzowska M; Marunowska A; Jundziłł W; Wodyńska T; Ruchalski M; Strzelecki A
Kardiol Pol; 1987; 30 Suppl():97-105. PubMed ID: 3331405
[No Abstract] [Full Text] [Related]
14. Isosorbide dinitrate ointment in Raynaud's disease.
Diehm C; Müller-Bühl U; Mörl H
Z Kardiol; 1983; 72 Suppl 3():185-7. PubMed ID: 6364591
[TBL] [Abstract][Full Text] [Related]
15. A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon.
Holti G
Practitioner; 1982 Apr; 226(1366):781-3. PubMed ID: 7045853
[No Abstract] [Full Text] [Related]
16. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
Lukác J; Rovenský J; Tauchmannová H; Zitnan D
Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
[TBL] [Abstract][Full Text] [Related]
17. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
Surwit RS; Gilgor RS; Allen LM; Duvic M
Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665
[TBL] [Abstract][Full Text] [Related]
18. Topical nitroglycerin ointment in Raynaud's phenomenon.
Fischer M; Reinhold B; Falck H; Török M; Alexander K
Z Kardiol; 1985 May; 74(5):298-302. PubMed ID: 3925656
[TBL] [Abstract][Full Text] [Related]
19. A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome.
Rustin MH; Grimes SM; Kovacs IB; Cooke ED; Bowcock SA; Sowemimo-Coker SO; Turner P; Kirby JD
Eur J Clin Pharmacol; 1984; 27(1):61-5. PubMed ID: 6386490
[TBL] [Abstract][Full Text] [Related]
20. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control].
Dumoulin J
Electrodiagn Ther; 1981; 18(4):168-74. PubMed ID: 6279383
[No Abstract] [Full Text] [Related]
[Next] [New Search]
